Puma shares triple on positive PhIII neratinib data, plans to file for approval

John Carroll FierceBiotech News

With a $650M gift and a trove of genomic data, Broad sets out to innovate in schizophrenia

Damian Garde Scientists from the Broad Institute are unveiling new genomic findings from thousands of schizophrenia patients that could lead to new molecular targets. And, thanks to ...

Shooting for early OK, Sarepta lays out promising 3-year data on Duchenne drug

John Carroll FierceBiotech News

EMA board agrees to approve revised trial data policy

Emily Mullin The management board of the European Medicines Agency (EMA) agreed on June 12 to approve a new policy that would require drug companies to share certain clinical trial ...

AstraZeneca touts arthritis, lupus data with a rosy view of its pipeline

Damian Garde Two key investigational drugs came through in mid-stage studies, providing some ballast for the drugmaker as it boasts the value of its pipeline in an effort to ward off ...

Biopsy snafu torpedoes PhII prostate cancer data for Nymox

John Carroll A high rate of incorrect biopsies has tangled the mid-stage results for Nymox Pharmaceutical’s experimental prostate cancer drug. Investigators say that NX-1207 reduced ...

Novartis hopes new COPD study data will draw patients from Glaxo’s Advair

Carly Helfand Novartis' generic of Advair in Europe is already a thorn in GlaxoSmithKline's side when it comes to sales of the declining blockbuster. Now, it says, another of ...

New data positions Astellas prostate cancer med Xtandi to grab market share from J&J’s Zytiga

Tracy Staton Some new data on the prostate cancer drug Xtandi promises to heat up competition with Johnson & Johnson's Zytiga. Medivation and its partner Astellas Pharma unveiled ...

FDA data breach startles drugmakers concerned about sensitive data

Damian Garde Hackers have found their way into the FDA's data vaults on investigational drugs, and industry groups are urging the agency to undergo a third-party audit to make sure ...

Peregrine Shares Bavituximab Data

mia.burns Data Presentation at Society for Immunotherapy of Cancer Annual Meeting Supports Potential of Peregrine Pharmaceuticals’ Novel Immunotherapy Bavituximab in Combination ...

Supernus Announces Release of New Clinical Data on Trokendi XR

barbara.lempert Supernus Announces Release of Exciting New Clinical Data on Trokendi XR(TM) ROCKVILLE, Md., Nov. 6, 2013 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), ...

Study: Drug developers routinely–and unethically–leave trial data in the dark

John Carroll Drug companies routinely herald their concern for patients as the leading reason why they spend billions of dollars on drug research. But a new study questions Big Pharma's ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS